Gene Therapy
Page 2 • 3 itemsUnlock global gene therapy market insights. Stay ahead on regulatory approvals, clinical trials, and investment opportunities in this cutting-edge biotech sector.
AskBio's Ametefgene Parvec Enters Phase II Trial for Parkinson's Disease Gene Therapy
AskBio advances Ametefgene parvec (AB-1005) to Phase II trials for Parkinson's disease using commercial-scale manufacturing at Viralgen facility.
Gene Therapy Market to Reach $43.8 Billion by 2034 as CRISPR and AAV Technologies Drive 12.27% Annual Growth
Gene therapy market projected to grow 12.27% annually through 2034, driven by CRISPR and AAV advances, with North America leading at 56% market share.
MeiraGTx Acquires Botaretigene Sparoparvovec Gene Therapy from Johnson & Johnson for X-linked Retinitis Pigmentosa Treatment
MeiraGTx acquired botaretigene sparoparvovec from J&J to treat X-linked retinitis pigmentosa, planning immediate global regulatory filings for approval.